ArticleInternational journal of analytical chemistry2026
Determination of 5-Hydroxymethylfurfural Content in Marketed Honey: A Modified RP-HPLC Method.
Article in International journal of analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Determination of 5-Hydroxymethylfurfural Content in Marketed Honey: A Modified RP-HPLC Method.International journal of analytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Honey is a nutritive sugar alternative, well-accepted over decades due to its natural source, and a global populace drive toward natural and healthier lifestyle options. Its quality assessment includes 5-hydroxymethylfurfural (5-HMF) content, which measures freshness, but has been linked to cancer. The ability to test for this neo-formed contaminant, 5-HMF, should therefore not be compromised, even in a resource-constrained setting. In this study, a modified reversed-phase HPLC method for the assay of 5-HMF levels in honey has been developed. A nonpolar C-18 column of dimension 3.0 × 150 mm; 2.7 μm was the stationary phase of choice, while a combination of 10:90% v/v of methanol and distilled water, with 1% formic acid, was employed as the mobile phase. Detection was by diode array at a wavelength of 295 nm, using an injection volume of 1 μL. At a flow rate of 0.5 mL/min, the total runtime of the method was 8 min, with the average retention time for 5-HMF recorded at 3.87 ± 0.05 min. Validation of the method was conducted using International Council for Harmonisation guidelines, over the range of 1.25-30.0 μg/mL. It was further employed to quantify 5-HMF in 20 honey samples on the Ghanaian market with varying origin, extraction source and production state, using methanol as the dissolution solvent to ensure stability of the target compound throughout the analysis. 5-HMF levels assayed in the honey samples ranged from 0.8176 ± 0.182 to 81.1619 ± 2.1169 mg/kg of honey. At the time of analysis, 5-HMF contents of all samples except one were within the acceptable limit of ≤ 80 mg/kg of honey, set by the International Honey Commission. The 5-HMF levels quantified in market samples approved by Ghana's Food and Drugs Authority were within the acceptable limit. The developed method is comparatively cheaper and can be successfully used to analyse 5-HMF in honey samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.